| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,791 |
4,705 |
$514K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,551 |
3,792 |
$277K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,058 |
956 |
$58K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
928 |
862 |
$54K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
987 |
857 |
$38K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
648 |
592 |
$37K |
| 99215 |
Prolong outpt/office vis |
318 |
278 |
$36K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
450 |
420 |
$25K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
510 |
429 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,788 |
1,122 |
$12K |
| 90686 |
|
631 |
573 |
$11K |
| 99354 |
|
144 |
118 |
$9K |
| 92551 |
|
1,707 |
1,515 |
$7K |
| 99173 |
|
1,659 |
1,482 |
$7K |
| 90651 |
|
322 |
288 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
532 |
446 |
$5K |
| 90621 |
|
317 |
259 |
$5K |
| 90670 |
|
273 |
240 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
227 |
193 |
$4K |
| 87430 |
|
198 |
178 |
$2K |
| 81002 |
|
639 |
568 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
734 |
532 |
$979.00 |
| 90688 |
|
51 |
51 |
$951.22 |
| 90734 |
|
36 |
32 |
$633.28 |
| 90658 |
|
35 |
33 |
$594.12 |
| 90648 |
|
34 |
28 |
$554.12 |
| 90744 |
|
28 |
24 |
$474.96 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
13 |
12 |
$359.64 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
39 |
29 |
$319.00 |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
17 |
16 |
$313.82 |
| 90698 |
|
15 |
13 |
$257.27 |
| 90680 |
|
13 |
12 |
$237.48 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
13 |
12 |
$74.47 |
| 36415 |
Collection of venous blood by venipuncture |
37 |
37 |
$72.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
328 |
250 |
$57.59 |
| 94760 |
|
69 |
61 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
16 |
14 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
13 |
12 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
17 |
13 |
$0.00 |